mega genomics
Launch date
Employees
Market cap
CAD303m
Enterprise valuation
CAD218m (Public information from Sep 2024)
Share price
HKD7.91 6667.HK
Haidian Beijing (HQ)
Financials
Estimates*
| CNY | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenues | 124m | 203m | 237m | 146m | 151m |
| % growth | - | 64 % | 17 % | (39 %) | 4 % |
| EBITDA | 78.4m | 125m | 120m | 17.8m | 35.5m |
| % EBITDA margin | 63 % | 61 % | 51 % | 12 % | 23 % |
| Profit | 29.7m | 79.1m | 79.0m | (17.6m) | 30.0m |
| % profit margin | 24 % | 39 % | 33 % | (12 %) | 20 % |
| EV / revenue | - | - | - | 16.1x | 11.5x |
| EV / EBITDA | - | - | - | 132.2x | 49.2x |
| R&D budget | 4.4m | 4.4m | 11.4m | - | - |
| R&D % of revenue | 4 % | 2 % | 5 % | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | $450k | Angel | |
$1.5m | Series A | ||
| N/A | $61.3m | - | |
* | N/A | - | |
* | N/A | $20.0m | IPO |
| Total Funding | CAD86.2m | ||